Recombinant Human NSDHL Protein，His

NSDHL (NAD(P)H-dependent steroid dehydrogenase-like) is an enzyme that plays a critical role in the late stages of cholesterol biosynthesis and the metabolism of sterols. Mutations in the NSDHL gene are associated with X-linked dominant chondrodysplasia punctata (XLDCP), a disorder characterized by skeletal abnormalities and distinctive skin lesions. Understanding the structure and function of NSDHL is essential for elucidating the biochemical pathways involved in cholesterol metabolism and related diseases. Research on NSDHL recombinantly expressed proteins has become increasingly important in the field of molecular biology and biochemistry. By producing and characterizing NSDHL in vitro, scientists can investigate its enzymatic activities, substrate specificity, and interactions with other proteins involved in sterol biosynthesis. This research not only sheds light on the pathological mechanisms underlying XLDCP but also holds potential implications for therapeutic strategies targeting cholesterol-related disorders. Advances in recombinant protein technology have facilitated the expression of NSDHL in various host systems, leading to improved purification methods and functional assays. These developments contribute to a deeper understanding of NSDHL's role in cellular metabolism and may pave the way for novel treatments for patients with genetic mutations affecting this crucial enzyme. Ultimately, studying NSDHL and its recombined forms is vital for expanding our knowledge of lipid metabolism and developing interventions for related diseases.